Psoriatic Arthritis Medication Brepocitinib Reduced Symptoms by 20% in Phase 2 Trial
A new clinical trial shows potential for the drug brepocitinib to treat psoriatic arthritis, reducing symptoms by as much as 20%. A new clinical trial shows potential for the…